Pentixapharm Holding AG (XTER:PTP) Operating Margin %: 0.00% (As of Mar. 2026)


XTER:PTP Pentixapharm Holding AG XTER:PTP
12 GF Score
Price €2.10
! 2 Warning Signs
View Full Analysis

What is Pentixapharm Holding AG Operating Margin %?

Pentixapharm Holding AG XTER:PTP +4.48% 12 Operating Margin % is 0.00% as of Mar. 2026. GuruFocus rates XTER:PTP with a GF Score™ of 12/100. The stock has 2 warning signs investors should review. Among 945 Biotechnology companies, Pentixapharm Holding AG ranks worse than 96.08% on this metric.

Operating Margin % is calculated as Operating Income divided by its Revenue. Pentixapharm Holding AG's Operating Income for the three months ended in Mar. 2026 was €-3.04 Mil. Pentixapharm Holding AG's Revenue for the three months ended in Mar. 2026 was €0.00 Mil. Therefore, Pentixapharm Holding AG's Operating Margin % for the quarter that ended in Mar. 2026 was 0.00%.

The historical rank and industry rank for Pentixapharm Holding AG's Operating Margin % or its related term are showing as below:

XTER:PTP' s Operating Margin % Range Over the Past 10 Years
Min: -25670.83   Med: -14899.15   Max: -2783.05
Current: -24982.43


XTER:PTP's Operating Margin % is ranked worse than
96.08% of 945 companies
in the Biotechnology industry
Industry Median: -86.89 vs XTER:PTP: -24982.43

Pentixapharm Holding AG's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.

Pentixapharm Holding AG's Operating Income for the three months ended in Mar. 2026 was €-3.04 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Mar. 2026 was €-18.49 Mil.


Pentixapharm Holding AG  (XTER:PTP) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Pentixapharm Holding AG Operating Margin % Related Terms


Pentixapharm Holding AG Operating Margin % Historical Data

* Premium members only.

The historical data trend for Pentixapharm Holding AG's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pentixapharm Holding AG Operating Margin % Chart

Pentixapharm Holding AG Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Operating Margin %
-2,783.05 -7,019.35 -25,670.83 -14,899.15 -21,059.14

Pentixapharm Holding AG Quarterly Data
Dec21 Dec22 Dec23 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -21,884.21 -23,873.68 -5,764.56 26,491.67 0.00

XTER:PTP vs VRTX, REGN, ALNY: Operating Margin % Comparison

For the Biotechnology subindustry, Pentixapharm Holding AG's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pentixapharm Holding AG Operating Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pentixapharm Holding AG's Operating Margin % distribution charts can be found below:

* The bar in red indicates where Pentixapharm Holding AG's Operating Margin % falls into.


XTER:PTP
12GF Score
Pentixapharm Holding AG XTER:PTP
Operating Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pentixapharm Holding AG Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Pentixapharm Holding AG's Operating Margin % for the fiscal year that ended in Dec. 2025 is calculated as

Operating Margin %=Operating Income (A: Dec. 2025 ) / Revenue (A: Dec. 2025 )
=-19.585 / 0.093
=-21,059.14 %

Pentixapharm Holding AG's Operating Margin % for the quarter that ended in Mar. 2026 is calculated as

Operating Margin %=Operating Income (Q: Mar. 2026 ) / Revenue (Q: Mar. 2026 )
=-3.039 / 0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Operating Margin % →
What does a Operating Margin % of 0.00% mean?
Pentixapharm Holding AG (XTER:PTP) has a Operating Margin % of 0.00% as of Mar. 2026. Operating margin is the ratio of total operating income to net sales. View historical data on Pentixapharm Holding AG and its competitors. According to the industry distribution chart, Pentixapharm Holding AG ranks #908 out of 945 companies in the Biotechnology industry, placing it in the top 96.1%.
Is Pentixapharm Holding AG's Operating Margin % too high?
Pentixapharm Holding AG's current Operating Margin % is 0.00%. Based on the distribution chart, Pentixapharm Holding AG ranks #908 out of 945 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Pentixapharm Holding AG has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Pentixapharm Holding AG's Operating Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Pentixapharm Holding AG ranks #908 out of 945 companies for Operating Margin %. This places Pentixapharm Holding AG in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Biotechnology company?
A good Operating Margin % depends on the Biotechnology industry context. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Pentixapharm Holding AG and its competitors. Pentixapharm Holding AG's current Operating Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pentixapharm Holding AG stock overvalued right now?
Pentixapharm Holding AG (XTER:PTP) has a current Operating Margin % of 0.00%. The current Operating Margin % is 0.00%. Pentixapharm Holding AG's overall GF Score™ is 12/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Pentixapharm Holding AG (XTER:PTP), the current Operating Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Pentixapharm Holding AG Business Description

Other Exchanges PTPN:Austria
Address Robert-Rossle-Street 10, Berlin, DEU, 13125
Pentixapharm Holding AG is a clinical-stage biopharmaceutical company active in the field of research and development of radiopharmaceuticals for diagnostic and therapeutic applications. Radiopharmaceuticals are medical substances containing radioactive elements used in nuclear medicine to diagnose or treat diseases. Its clinical pipeline encompasses PentixaTher, a Yttrium-90 based therapeutic against non-Hodgkin lymphomas (NHL), and PentixaFor, a Gallium-68-based companion diagnostic. Its Pipeline products include: Pentixa Ther, PT-002, PentixaFor, PT-001, PentixaFor, PT-001, PT-00X, GT-001, GT-002, GT-005, GT-008, and GT-00X.
12GF Score

Get the complete analysis for XTER:PTP

Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.10
Price